The Ontario Paediatric Bariatric Network (OPBN) is comprised of 11 clinics that provides specialized paediatric bariatric services to children and youth who are overweight or obese. The OPBN identifies priorities and recommend strategies to advance a coordinated system of services, address service gaps, and improve quality of care over time across community and hospital settings, […]
Ontario Paediatric Bariatric Network Read More »
The OPR replaces the Ontario Antenatal Record 1 and 2. Please order the new OPR and destroy remaining Antenatal 1 and 2 forms. The updated Ontario Perinatal Record is the 5th revision and replaces the 2005 version. The OPR update and User Guide development was undertaken in 2017 by a provincial committee representing practitioners using the current
Ontario Perinatal Record (OPR) Read More »
In 2017, PCMCH, in partnership with Health Quality Ontario and the Champlain Maternal Newborn Regional Program, developed recommendations for emergency department (ED) healthcare providers and staff in providing compassionate care to people experiencing an early pregnancy loss in the ED. It is estimated that one in five pregnant individuals will experience an early pregnancy loss, defined
Early Pregnancy Loss in the Emergency Department Read More »
Please note: The PCMCH ED Clinical Pathway for Children and Youth with Mental Health Conditions was developed in 2013. The contents of the pathway are valid as of the time of publication. The ED Clinical Pathway for Children and Youth with Mental Health Conditions and the related decision-support tools were developed to guide and support
The overarching goal of the Paediatric Diabetes Network (PDN) is to ensure the best possible health outcomes for children and youth with diabetes in Ontario. The PDN is comprised of 35 specialized paediatric diabetes education programs (PDEPs); there are currently five tertiary-level PDEPs located in Toronto, Ottawa, London, Hamilton and Kingston, and 30 secondary-level PDEPs
Paediatric Diabetes Network Read More »
Fetal Fibronectin (fFN) testing helps clinicians to determine if a pregnant person who may be at risk of pre-term birth should be admitted to hospital and/or transferred to a high-risk perinatal unit. Evaluation of the testing protocol revealed significant cost savings to health provider organizations and the system as a whole, and suggested increased quality
Fetal Fibronectin Testing Read More »
What was originally developed as a Quality-Based Procedure (QBP) for Hyperbilirubinemia has been revised and updated into a best evidence Clinical Pathway for Hyperbilirubinemia in Term and Late Pre-Term Infants (> 35 weeks). The contents of this Clinical Pathway Handbook provide guidance to clinicians to ensure all newborns receive bilirubin screening between 24 and 72
Hyperbilirubinemia Screening: Clinical Pathway Handbook Read More »
